Tag: otoferlin
Sensorion Receives Rare Pediatric Disease Designation from the US Food and Drug Administration for the treatment of hearing loss related to the otoferlin gene – 11/07/2022 at 07:30
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company dedicated to developing innovative therapies to restore, treat and prevent hearing loss, announces that the U.S. Food and Drug Administration (FDA)…